Harvard Bioscience, Inc. (HBIO)
0.767
+0.05
(+6.47%)
USD |
NASDAQ |
Dec 10, 16:00
0.78
+0.01
(+1.69%)
After-Hours: 18:32
Harvard Bioscience Profit Margin (Quarterly): -5.98% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Bruker Corp. | -6.80% |
| Azenta, Inc. | 32.45% |
| Precipio, Inc. | -1.17% |
| Bionano Genomics, Inc. | -115.4% |
| Kestra Medical Technologies Ltd. | -133.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -155.3% |
| Return on Assets | -54.29% |
| Return on Invested Capital | -68.29% |
| Gross Profit Margin (Quarterly) | 54.23% |
| Operating Margin (Quarterly) | 1.19% |
| Return on Net Operating Assets | -61.82% |